Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2013) 32 P730 | DOI: 10.1530/endoabs.32.P730

1University of Singapore, Singapore, Singapore; 2University of Sydney, Sydney, Australia.


Introduction: The effect of BMI on mortality amongst the elderly may be different from younger adults. Thus, this study aims to determine the relationship between BMI and its 5-year changes on all-cause and cause-specific mortality in the elderly.

Methods: During 1992–1994, the Blue Mountains Eye Study recruited 3654 residents aged ≥49 years in Sydney, Australia. Of these, 75% of survivors returned for follow-up at 5 years. We initially examined the relationship between baseline BMI and mortality nonparametrically using cubic spline. Cox and competing risk models were used to assess associations of baseline BMI and its 5-year changes with all-cause and cause-specific mortality.

Results: Underweight persons were more likely to be older (mean 66.9, S.D. 9.9 years) and predominantly female (74%). Conversely, obese persons were more likely to be younger (mean 63.7, S.D. 8.3 years), and to have a history of pre-existing disease (hypertension, diabetes, angina, AMI and stroke; 54.5%). Amongst subjects without pre-existing disease, the relationship between baseline BMI and all-cause mortality was U-shaped, with the underweight and obese groups being predisposed to have a greater risk of death. In particular, obesity was associated with coronary heart disease (CHD; hazard ratio (HR) 2.78, 95% CI: 1.34–5.77) and cancer (HR 1.90, 95% CI: 1.08–3.12) deaths. For subjects with pre-existing disease, however, an inverse relationship was observed, with the underweight having a lower risk of death. Five-year reductions in BMI were associated with all-cause, cancer and CHD deaths.

Conclusion: Obesity affects all-cause, CHD and cancer mortality only amongst the elderly without pre-existing disease. BMI loss was associated with major causes of mortality. Understanding the varying impact of obesity on mortality amongst the elderly with and without pre-existing disease will provide clinicians and public health policymakers with critical evidence for disease management, resource planning and allocation.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts